Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Antiviral activities in human saliva.

Malamud D, Abrams WR, Barber CA, Weissman D, Rehtanz M, Golub E.

Adv Dent Res. 2011 Apr;23(1):34-7. doi: 10.1177/0022034511399282. Review.

2.

gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction.

Wu Z, Golub E, Abrams WR, Malamud D.

AIDS Res Hum Retroviruses. 2004 Jun;20(6):600-7.

PMID:
15242536
3.

Staphylococcus aureus SasA is responsible for binding to the salivary agglutinin gp340, derived from human saliva.

Kukita K, Kawada-Matsuo M, Oho T, Nagatomo M, Oogai Y, Hashimoto M, Suda Y, Tanaka T, Komatsuzawa H.

Infect Immun. 2013 Jun;81(6):1870-9. doi: 10.1128/IAI.00011-13. Epub 2013 Feb 25.

4.

Antimicrobial defense systems in saliva.

van 't Hof W, Veerman EC, Nieuw Amerongen AV, Ligtenberg AJ.

Monogr Oral Sci. 2014;24:40-51. doi: 10.1159/000358783. Epub 2014 May 23. Review.

PMID:
24862593
5.

Scavenger receptor gp340 aggregates group A streptococci by binding pili.

Edwards AM, Manetti AG, Falugi F, Zingaretti C, Capo S, Buccato S, Bensi G, Telford JL, Margarit I, Grandi G.

Mol Microbiol. 2008 Jun;68(6):1378-94. doi: 10.1111/j.1365-2958.2008.06220.x. Epub 2008 Apr 29.

6.

Review: Gp-340/DMBT1 in mucosal innate immunity.

Madsen J, Mollenhauer J, Holmskov U.

Innate Immun. 2010 Jun;16(3):160-7. doi: 10.1177/1753425910368447. Epub 2010 Apr 23. Review.

PMID:
20418254
7.

[Influence of saliva on plaque development].

van Nieuw Amerongen A.

Ned Tijdschr Tandheelkd. 1991 Mar;98(3):92-3. Dutch.

PMID:
1961328
8.

Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties.

Loimaranta V, Jakubovics NS, Hytönen J, Finne J, Jenkinson HF, Strömberg N.

Infect Immun. 2005 Apr;73(4):2245-52.

9.

Endogenous mucosal antiviral factors of the oral cavity.

Shugars DC.

J Infect Dis. 1999 May;179 Suppl 3:S431-5. Review.

PMID:
10099113
10.

Salivary proteins: protective and diagnostic value in cariology?

Van Nieuw Amerongen A, Bolscher JG, Veerman EC.

Caries Res. 2004 May-Jun;38(3):247-53. Review.

11.

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

Wahl SM, McNeely TB, Janoff EN, Shugars D, Worley P, Tucker C, Orenstein JM.

Oral Dis. 1997 May;3 Suppl 1:S64-9. Review.

PMID:
9456660
12.

Saliva and dental caries.

Dowd FJ.

Dent Clin North Am. 1999 Oct;43(4):579-97. Review.

PMID:
10553245
13.
14.

Oral transmission of HIV, reality or fiction? An update.

Campo J, Perea MA, del Romero J, Cano J, Hernando V, Bascones A.

Oral Dis. 2006 May;12(3):219-28. Review.

PMID:
16700731
15.

Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

Wahl SM, Worley P, Jin W, McNeely TB, Eisenberg S, Fasching C, Orenstein JM, Janoff EN.

Am J Pathol. 1997 Apr;150(4):1275-84.

16.
17.

Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro.

Haukioja A, Loimaranta V, Tenovuo J.

Oral Microbiol Immunol. 2008 Aug;23(4):336-43. doi: 10.1111/j.1399-302X.2008.00435.x.

PMID:
18582334
18.

Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors.

Jakubovics NS, Kerrigan SW, Nobbs AH, Strömberg N, van Dolleweerd CJ, Cox DM, Kelly CG, Jenkinson HF.

Infect Immun. 2005 Oct;73(10):6629-38.

19.

Supplemental Content

Support Center